ANUH PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 248.8 INR | -2.66% |
|
+3.30% | +69.68% |
| Apr. 08 | Anuh Pharma Limited Approves Final Dividend for the Financial Year Ended 2022-2023 | CI |
| Apr. 04 | Anuh Pharma Limited Appoints Manan Jayesh Vadhan as Company Secretary and Compliance Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Anuh Pharma Limited is an India-based bulk drug manufacturing company. The Company is engaged in the business of manufacturing active pharmaceutical ingredients (API). The Company manufactures Macrolides, Anti-TB, Anti-Bacterials, Anti-Malarial, Anti-Hypertension, Expectorant and Corticosteroids products. Its Macrolides products include Erythromycin, Erythromycin Ethyl Succinate, Erythromycin Stearate, Erythromycin Estolate, Erythromycin Propionate, Erythromycin Phosphate, Erythromycin 11,12 Carbonate and Azithromycin. Its Anti-TB products include Pyrazinamide and Isoniazid. Its Anti-Malarial products include Sulfadoxine and Pyrimethamine. Anti-Bacterials products include Chloramphenicol and Chloramphenicol Palmitate. Anti-Hypertension products include Losartan Potassium, Telmisartan and Atorvastatin Calcium. Its Expectorant product includes Ambroxol Hydrochloride. Its Quinolones product includes Moxifloxacin Hydrochloride.
Sector
Pharmaceuticals
Calendar
2024-05-29
- Q4 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +69.68% | 154M | |
| +20.81% | 43.34B | |
| +20.44% | 21.96B | |
| +12.82% | 14.09B | |
| +12.97% | 13.64B | |
| +39.74% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- ANUHPHR6 Stock
- News Anuh Pharma Limited
- Anuh Pharma Gets European Regulator's Nod for Anti-Malarial Drug
